GLP-1 medications , or glucagon-like peptide-1 receptor agonists , represent a substantial innovation in how we handle type 2 diabetes . These injectable therapies function to stimulating the body’s https://bookmarketmaven.com/story22617872/glp-1-a-significant-breakthrough-in-diabetes-management